Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-9.42%
↑ 43% above average
Average (24q)
-16.48%
Historical baseline
Range
High:66.42%
Low:-199.46%
Volatility
-1613.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -9.42% |
| Q2 2025 | -13.61% |
| Q1 2025 | 7.84% |
| Q4 2024 | -11.97% |
| Q3 2024 | -41.63% |
| Q2 2024 | 11.94% |
| Q1 2024 | -199.46% |
| Q4 2023 | 66.42% |
| Q3 2023 | -32.56% |
| Q2 2023 | 4.29% |
| Q1 2023 | -17.33% |
| Q4 2022 | 13.93% |
| Q3 2022 | -9.98% |
| Q2 2022 | -10.50% |
| Q1 2022 | -8.65% |
| Q4 2021 | -18.71% |
| Q3 2021 | -15.80% |
| Q2 2021 | -87.79% |
| Q1 2021 | -3.03% |
| Q4 2020 | -58.13% |
| Q3 2020 | 43.05% |
| Q2 2020 | -26.18% |
| Q1 2020 | 4.55% |
| Q4 2019 | 0.66% |
| Q3 2019 | 0.00% |